Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.
Fischer, S. and Zechmeister-Koss, I (2012): Day Surgery. HTA- Projektbericht 64.
Gugerbauer, J. and Warmuth, M. (2011): Radiofrequency ablation for hepatocellular carcinoma and colorectal liver metastases. Decision Support Document 049.
Haute Autorité de Santé (HAS), EUnetHTA and Autoridade Nacional do Medicamento e Productos de Saude (INFARMED), EUnetHTA (2017): Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma (HCC) who have previously been treated with sorafenib. EUnetHTA report. DSD: Horizon Scanning in Oncology 73.
Kisser, A. (2016): Hepatitis C virus screening in hospitals. Decision Support Document 102.
Nachtnebel, A. and Sotti, G. and Vitale, A. and Perrini, MR. (2011): Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignancies. German version. Decision Support Document 47.
Nachtnebel, A. and Sotti, G. and Vitale, A. and Perrini, MR. (2011): Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignancies. English version. Decision Support Document 47.
Rothschedl, E. and Nachtnebel, A. (2015): Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease. Decision Support Document 84.
Schmidt , L. and Lohr, P. and Prenner, A. and Poerio, E. and Ceresola, E. and Andretta, M. and Cavazzana, A. (2019): Robot-assisted surgery in thoracic and visceral indications. HTA-Projektbericht 108.
Wild, C. (2004): [Prevention and therapy of Hepatitis C]. HTA-Newsletter 29: 3-4.
Wild, C. (2004): [ERCP vs. MRCP: Diagnostics of biliary tract diseases]. HTA-Newsletter 27: 2-3.
Wild, C. (2004): [Photodynamic therapy/PDT]. HTA-Newsletter 27: 4.
Wild, C. (2004): [Radiofrequency ablation: Therapy of liver tumours] . HTA-Newsletter 26: 4.
Wild, C. (2003): [MARS® liver support]. HTA-Newsletter 20: 2.
Wild, C. (2003): [Pegylated interferon alpha for chronic hepatitis C]. HTA-Newsletter 17: 3-4.
Wild, C. (2002): [Living donor transplantation]. HTA-Newsletter 11: 3-4.
Wild, C. (2002): [Laser-induced thermotherapy (LITT) in the treatment of malignant tumours]. HTA-Newsletter 06: 2.
Wild, C. and Patera, N. (2014): Stereotactic Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases. Decision Support Document 76.
Zapata Cachafeiro, M. and Varela Lema, L. and Faraldo Vallés, M.J. and Fuchs, E. (2019): Irreversible electroporation for the treatment of liver and pancreatic cancer. HTA-Projektbericht 119.